AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|
21 C
New York
Monday, September 14, 2026

Tag: cause

newssourceFORcompanyinformationcontent1releasesmarket

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program.

DeFi Development Corp. to Host X Spaces Event: “July 2025 Business Recap & AMA”

BOCA RATON, FL, Aug. 01, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Monday, August 4, 2025, at 1:30 p.m. Eastern Time, titled “July 2025 Business Recap & AMA.”

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

Barranco Gold Mining Corp. in Final Negotiations to Acquire Strategic Mineral Claims

CSE: BAR FWB: 314 NORTH VANCOUVER, BC, Aug. 1, 2025 /PRNewswire/ - Barranco Gold Mining Corp. ("Barranco" or the "Company") is pleased to announce that it is...

Barranco Gold Mining Corp. in Final Negotiations to Acquire Strategic Mineral Claims

CSE: BAR FWB: 314 NORTH VANCOUVER, BC, Aug. 1, 2025 /CNW/ - Barranco Gold Mining Corp. ("Barranco" or the "Company") is pleased to announce that it is...

MiRus Receives New Technology Add-on Payment (NTAP) for EUROPA™ Posterior Cervical Fusion System

ATLANTA, Aug. 1, 2025 /PRNewswire/ -- MiRus has received New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS) for...

Orca Energy Group Inc. announces arbitrations against the United Republic of Tanzania and Tanzania Petroleum Development Corporation over US$1.2 billion Project

Orca announces arbitrations against the United Republic of Tanzania and Tanzania Petroleum Development Corporation over US$1.2 billion Project

Erayak Power Solution Group Inc. Announces Closing of $7 Million Registered Direct Offering

Wenzhou, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Erayak Power Solution Group Inc. (NASDAQ: RAYA) ("Erayak" or the "Company"), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, today announced the closing of its previously announced registered direct offering with certain institutional investors for the sale and purchase of an aggregate of 107,692,307 of the Company’s  Class A ordinary shares, par value $0.0001 per share (the “Shares”) (or Class A ordinary share equivalents in lieu thereof) in a registered direct offering at a purchase price of $0.065 per share. The purchase price for the pre-funded warrants was $0.065 to the purchase price for Shares, less the exercise price of $0.0001 per share.

Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m

        

Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference

Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data  PITTSBURGH, Aug. 1, 2025 /PRNewswire/...

Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA

SHANGHAI, Aug. 1, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911,...

Innovative Food Holdings Announces it is Exiting the Cheese Conversion Business, Entering Agreement to Sell Pennsylvania Facility, and Relocating Remaining Profitable Operations to Chicago...

IVFH ANNOUNCES IT IS EXITING THE CHEESE CONVERSION BUSINESS, ENTERING AGREEMENT TO SELL PENNSYLVANIA FACILITY, RELOCATING REMAINING OPERATION TO CHICAGO

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule (IPPS) for fiscal year (FY) 2026, the Centers for Medicare & Medicaid Services (CMS) granted New Technology Add-On Payment (NTAP) reimbursement to cervical fusion procedures using the company’s aprevo® personalized interbody implants.

MacKenzie Realty Capital Announces Effective Date for 1-for-10 Reverse Stock Split

MacKenzie Realty Capital Announces Effective Date for 1-for-10 Reverse Stock Split

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCause

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers